Explore
Trendline
PHARMAP 2026 Highlights Shift in Pharma Outsourcing Strategies
PHARMAP 2026 Highlights Shift in Pharma Outsourcing Strategies
Read More
Trendline
bioMérieux Launches BIOFIRE SPOTFIRE for Rapid Mycoplasma Testing in Pharma
bioMérieux Launches BIOFIRE SPOTFIRE for Rapid Mycoplasma Testing in Pharma
Read More
Trendline
Gilead Sciences Shifts Focus to Integration After Series of Acquisitions
Gilead Sciences Shifts Focus to Integration After Series of Acquisitions
Read More
AP News
Toxic Mud? Hawaii's North Shore Flooding Likely Diluted Pesticide Risk
Residents on Hawaii's North Shore are dealing with mud and debris after severe flooding and have expressed concerns about potential exposure to toxic farm chemicals from upstream agricultural operations
Read More
Trendline
Simulations Plus Reports 8% Revenue Growth in Second Quarter Fiscal 2026
Simulations Plus Reports 8% Revenue Growth in Second Quarter Fiscal 2026
Read More
Trendline
PhRMA CEO Steve Ubl to Retire, Impacting Pharmaceutical Lobbying Landscape
PhRMA CEO Steve Ubl to Retire, Impacting Pharmaceutical Lobbying Landscape
Read More
Trendline
Cosette Pharmaceuticals Acquires U.S. Rights to SYMPAZAN and Other Products from Assertio
Cosette Pharmaceuticals Acquires U.S. Rights to SYMPAZAN and Other Products from Assertio
Read More
Trendline
Biotechnology Firms Drive Growth in High Potency API Market, Projected to Reach USD 69.13 Billion by 2035
Biotechnology Firms Drive Growth in High Potency API Market, Projected to Reach USD 69.13 Billion by 2035
Read More
Trendline
ConnectiveRx and EagleForce Launch ShieldRx to Combat Pharmacy Misuse
ConnectiveRx and EagleForce Launch ShieldRx to Combat Pharmacy Misuse
Read More
Trendline
CenExel Appoints Dr. Sy Pretorius as CEO to Drive Strategic Growth
CenExel Appoints Dr. Sy Pretorius as CEO to Drive Strategic Growth
Read More
Trendline
Apnimed Secures $150 Million Financing for Sleep Apnea Drug Development
Apnimed Secures $150 Million Financing for Sleep Apnea Drug Development
Read More
Trendline
Merck Adjusts Acquisition Offer for Terns Pharmaceuticals After Leukemia Data Update
Merck Adjusts Acquisition Offer for Terns Pharmaceuticals After Leukemia Data Update
Read More